UPDATED Apr 24, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£113.52 | 4.0% | -3.8% | UK£176.0b | UK£128.76 | PE37x | E16.7% | 2.0% | Pharmaceuticals & Biotech | ||
HSBK | US$18.22 | 5.3% | 40.2% | US$5.0b | US$23.60 | PB0.9x | E7.9% | 12.5% | Banks | ||
GRG | UK£27.80 | 0.07% | -0.7% | UK£2.8b | UK£32.20 | PE19.8x | E4.7% | 2.2% | Consumer Services | ||
FOUR | UK£63.10 | 1.8% | 37.8% | UK£1.8b | UK£70.44 | PE20.9x | E7.1% | 2.7% | Media |